- Brolucizumab - A New Player In The Field Of Anti-VEGF Therapy Of Neovascular Age-Related Macular Degeneration. A Review2022 | First Faculty of Medicine
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Age-related macular degeneration Age-related macular degeneration2021 | Faculty of Medicine in Hradec Králové
